IOL Chemicals and Pharmaceuticals (IOL) has received certificate of suitability from European Directorate for the Quality of Medicines & HealthCare (EDQM) to supply Pantoprazole Sodium Sesquihydrate active pharmaceutical ingredient (API) in European markets. The European Directorate for the Quality of Medicines & HealthCare is a mandatory certification for distribution of any API/ pharma products in Europe.
Pantoprazole Sodium Sesquihydrate, an API, is proton pump inhibitor used in drugs to suppress the gastric acid secretion. The company started production of Pantoprazole Sodium Sesquihydrate in Q3FY2020 at its Punjab-based facility. With this CEP (certificate of suitability) certification, the company will now be able to export it to entire Europe. IOL currently has a total capacity of producing 240 TPA of Pantoprazole Sodium Sesquihydrate.
IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: